Security key
89680M119
TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (TLSIW)
CUSIP: 89680M119
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / *W EXP 08/10/202
- Total 13F shares
- 1,023,822
- Total 13F value
- $1,230,280
- Share change
- -44,592
- SEC-reported price per share
- $1.20
- Number of holders
- 7
- Value change
- -$68,202
- Number of buys
- 2
- Number of sells
- 4
Report period
Q1 2026
Institutions
7
Top holders
7
TLSIW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
TriSalus Life Sciences, Inc. SEC filings
TriSalus Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89680M119
Recent filing periods:
Ownership snapshot
Top reported holders of TLSIW - TriSalus Life Sciences, Inc. - *W EXP 08/10/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frankenius Equity AB
Disclosed value leader
MedTech Acquisition Spons...
Comparable rows
4/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 14%
11 rows are not safely comparable across share classes.
13D/G row: Frankenius Equity AB
Showing 1-6 of 15 holder rows.
Quick read
Frankenius Equity AB leads the comparable SEC ownership view at 14%.
4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frankenius Equity AB's linked filing trail.
Comparable ownership
Top 4
Frankenius Equity AB
14%
Mats Wahlstrom
6%
Utmost Group Plc
5.7%
Nantahala Capital Management, LLC
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frankenius Equity AB |
13D/G
3/4/5
10%+ Owner
|
14%
Reported 13D/G
· 31 Jul 2025
|
$34,179,868
6,989,748 shares
|
+$1,257,864 | 31 Jul 2025 |
| Mats Wahlstrom |
13D/G
|
6%
Reported 13D/G
· 31 Jul 2025
|
$14,610,738
2,987,881 shares
|
+$931,271 | 31 Jul 2025 |
| Utmost Group Plc |
13D/G
|
5.7%
Reported 13D/G
· 31 Mar 2026
|
$14,644,149
3,503,385 shares
|
+$493,867 | 31 Mar 2026 |
| Nantahala Capital Management, LLC |
13F
13D/G
Company
|
4.1%
Reported 13D/G
· 30 Sep 2025
|
$14,454,372
2,070,827 shares
|
— | 31 Dec 2025 |
| MedTech Acquisition Sponsor LLC |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$65,538,115
6,250,000 shares
mixed-class rows
|
— | 26 Jun 2023 |
| Magnetar Financial LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$174,782
16,668 shares
|
— | 12 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
1,023,822
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
8
Q1 2026 holders
7
Holder diff
-1
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend